<DOC>
	<DOCNO>NCT01658449</DOCNO>
	<brief_summary>The purpose study compare tolerability acceptability formulation contain Hypertonic saline 7 % ( HS ) alone formulation contain HS Hyaluronic acid 0.1 % population Cystic Fibrosis ( CF ) patient already show poor tolerance HS .</brief_summary>
	<brief_title>Comparison Tolerability Two Formulations Hypertonic Saline Cystic Fibrosis Patients</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>diagnosis Cystic Fibrosis ( genotyping sweat test ) &gt; 8 yearold clinically therapeutically stable disease last 30 day ; Forced Expiratory Volume one second ( FEV1 ) ≥ 50 % predict value ; intolerance ( cough , throat irritation , saltiness ) previous administration 5.8 % hypertonic saline solution . decrease FEV1 &gt; 15 % first inhalation hypertonic saline ; Burkholderia cepacia infection ; infective exacerbation require antibiotic treatment 15 day precede enrolment ; patient non compliant standard therapy ; Lung transplant ; Patient unable perform reproducible spirometry ; Intolerance β2 bronchodilator ; Concurrent enrolment clinical trial ; Plasmatic creatinine transaminase twice normal value .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>